Who is sponsoring I-CPEP?

I-CPEP is sponsored by Clinical Research Centre, Malaysia.

What drugs are being tested in I-CPEP?

Interventions: Ivermectin, Placebo.

What is the status of I-CPEP?

I-CPEP is currently TERMINATED.

Last reviewed 2022-10-18 · How we verify

Ivermectin for Post Exposure Prophylaxis of Covid-19 (I-CPEP)

NCT05231603 PHASE3 TERMINATED

Post exposure prophylaxis of healthy contacts is among the measures used for outbreak control of several infectious diseases (e.g., pandemic influenza). No agent is known to be effective in preventing COVID-19, but Ivermectin is one of the drugs that have shown antiviral activity against SARS-CoV-2 in the laboratory. This study aims to evaluate the effect of post exposure prophylaxis with Ivermectin after exposure to COVID-19 among the asymptomatic close contacts.

Details

Lead sponsor	Clinical Research Centre, Malaysia
Phase	PHASE3
Status	TERMINATED
Enrolment	50
Start date	Wed Feb 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

COVID-19

Interventions

Ivermectin
Placebo

Countries

Malaysia